Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression.
about
Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemideDecynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depressionInvolvement of genetic and environmental factors in the onset of depressionEffect of long term amineptine treatment on pre- and postsynaptic mechanisms in rat brainRegulation of serotonin type 2 (5-HT2) and beta-adrenergic receptors in rat cerebral cortex following novel and classical antidepressant treatment.Antidepressants influence somatostatin levels and receptor pharmacology in brainTricyclic antidepressants vary in decreasing alpha 2-adrenoceptor sensitivity with chronic treatment: assessment with clonidine inhibition of acoustic startle.Pharmacologic approaches to the treatment of cocaine dependenceThe psychopathology and treatment of bipolar disorder.A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy.Bromocriptine-desipramine protocol in treatment of cocaine addiction.Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography.Biochemical pharmacology of paradoxical sleep.Genitourinary and sexual adverse effects of psychotropic medication.The neurobiology of depression: perspectives from animal and human sleep studies.Assessment of lithium ingestion on cognition and some subset of motor skill.Serotonergic and noradrenergic function in depression: clinical correlatesRegional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression.The effects of acute and chronic desipramine on the thermogenic and hypoactivity responses to alpha 2-agonists in reserpinized and normal miceStrategies for the drug treatment of depression.Frequency-dependent block of field potentials in the rat hippocampal slice caused by tricyclic antidepressants.Psychoactive drugs and human sexual behavior: the role of serotonergic activity.Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories.Monoamines: biochemical markers of suicide?Evolving conceptualizations of cocaine dependence.Lithium dampens neurotransmitter response in smooth muscle: relevance to action in affective illnessPharmacologic treatment of cocaine abuse.Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment.Synaptic and nonsynaptic cross talk between neurons. Role of presynaptic alpha 2-receptors in mental disorders.Alcoholism and panic disorder: is the comorbidity more than coincidence?Could the underestimation of bipolarity obstruct the search for novel antidepressant drugs?The neurobiology of depression.Serotonin function and human anxiety disorders.Monoamine theories of depression: historical impact on biomedical research.Antidepressants and serotonergic neurotransmission: an integrative review.Chronic depression. Issues in long-term management.Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.A primer on neurotransmitters and cocaine.Improvement of cocaine-induced neuromodulator deficits by the neuronutrient Tropamine.Neurochemical aspects of depression: the past and the future?
P2860
Q24535668-5A423444-DAF5-4AC5-8C69-2A90E92B95E3Q24611123-674BD3F5-C32F-416A-B5D0-9A36E308B412Q27027796-256042C4-3D67-448C-8CB9-ECDE8B4AAFA8Q28303410-1C60AC1A-F47F-407C-9060-C1D1050F4AD8Q28322232-6F2AAE37-BFB4-4B1D-B332-FD255F003DF8Q28568340-5E434A10-47F7-418D-91E5-D433419AC51FQ30498846-82E2A6DD-9DCC-44EE-AEF9-3C54FE0EFC2BQ33558229-35594B4E-0EEF-4C8B-852D-8D191252E3A8Q33619910-484FA93C-5871-47E6-8929-E3388BE93E25Q33658525-8D1599BE-A2A1-4677-9A70-01732522A206Q34173638-16F722F8-D854-4AAE-AE70-102956300AD6Q34348375-E8D4CD18-2AC4-4568-A84A-94BC1C685EBBQ34513911-680B0DF7-B53D-4DA6-ACD4-C379CB0FD391Q34539265-1807178D-6CDD-4244-A7DC-CAD89395EBEAQ35064092-66AED948-6627-42C0-BB7D-90122F931B4CQ35138006-BBD467BB-A15C-4298-A6A9-7FF129CAEE68Q35236257-BE314047-919F-4971-8D10-02BED956B308Q35601193-FECDE992-309F-4D54-9ED3-4281A0A5BE0FQ35756144-A9E482CC-27AC-46B5-B499-F9349E1DE8CDQ35807745-236866BF-F36C-4FA9-A97C-847101C3B602Q35886930-F95644C6-4463-4434-A3BF-C96A265D95B8Q36272836-C75C641E-5F83-4D13-B89E-B3652FA985C4Q36540629-47EEAF83-931B-49EE-B515-B1A4F2D42D50Q36558628-88451A11-A462-4587-8806-6FA5FF431A6CQ36989473-F02A8255-4DB8-49E8-81A1-3362533842D3Q37393344-79880773-7ED3-4950-B9DB-DC6CD8851918Q37508852-AE8B9897-9F2E-4E07-8A80-DD09B715C1E5Q37529769-115F2CFE-05E5-4497-83DB-7746157FD995Q37895595-5E2408EC-9557-4C4F-BB4B-032E8605D6D1Q37915749-578D1075-FB1D-4271-9E9D-5977D3AE518DQ37958033-E388481C-1425-47E6-8883-31310467595BQ37984000-FC6EF4BA-8EE5-49DC-827D-EE1B0F4DCC60Q38004479-0D265324-0C92-4B57-B66B-FDB715545E28Q38040538-C27AAA77-B7B5-45D5-A6C0-C29FC546F74DQ38151087-79121E0E-E898-4CDE-9A38-9D57111CAE2EQ38219986-91451D0F-3BBB-43A6-813F-9BD4CFD4E04EQ38573611-A0B7E263-2AC4-4882-82A0-2C74257751A8Q39472659-E4FC8926-0802-49B3-BD06-1E13CD1A3D95Q39472665-78EEAAF5-D35A-4230-B278-C9BC05CEE605Q39495395-D85EF9B1-7465-41F6-BA10-F60C3AAE6653
P2860
Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Receptor sensitivity and the m ...... ogy and therapy of depression.
@en
type
label
Receptor sensitivity and the m ...... ogy and therapy of depression.
@en
prefLabel
Receptor sensitivity and the m ...... ogy and therapy of depression.
@en
P2093
P1433
P1476
Receptor sensitivity and the m ...... ogy and therapy of depression.
@en
P2093
Charney DS
Heninger GR
P304
P356
10.1001/ARCHPSYC.1981.01780350094011
P407
P577
1981-10-01T00:00:00Z